BNP Paribas Asset Management’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-41,623
Closed -$1.02M 865
2020
Q3
$1.02M Sell
41,623
-1,412,714
-97% -$30.5M 0.01% 675
2020
Q2
$26M Sell
1,454,337
-2,432,715
-63% -$32M 0.18% 156
2020
Q1
$31.6M Buy
3,887,052
+753,403
+24% +$8.61M 0.27% 109
2019
Q4
$41.4M Buy
3,133,649
+262,803
+9% +$3.18M 0.28% 106
2019
Q3
$34.1M Buy
2,870,846
+1,477,672
+106% +$27.4M 0.26% 103
2019
Q2
$34.1M Buy
1,393,174
+601,881
+76% +$17.3M 0.28% 91
2019
Q1
$25.2M Buy
+791,293
New +$28.1M 0.21% 130

Other funds holding CVET

BNP Paribas Asset Management's CVET Position: Q4 2020 in Review

BNP Paribas Asset Management sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2020, closing a stake of 41,623 shares — an estimated $1.02M sold.

BNP Paribas Asset Management first reported a position in CVET in Q1 2019 and held it in 7 quarters. The position peaked at $41.4M in Q4 2019. 277 funds tracked by Wall St. Rank hold CVET as of Q4 2020.

  • BNP Paribas Asset Management reported no remaining Covetrus, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • BNP Paribas Asset Management sold 41,623 Covetrus, Inc. Common Stock shares in Q4 2020, an estimated $1.02M.
  • BNP Paribas Asset Management first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 7 quarters.
  • BNP Paribas Asset Management's Covetrus, Inc. Common Stock position peaked at $41.4M in Q4 2019.
  • 277 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2020.

Based on BNP Paribas Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.